Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × FCN-437c × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor, Adult 1

Interventions

Injections 80 pembrolizumab 79 Paclitaxel 53 Carboplatin 53 Cisplatin 48 Docetaxel 40 Nivolumab 36 Pemetrexed 34 Gemcitabine 34 atezolizumab 28 Bevacizumab 28 tislelizumab 27 Fluorouracil 23 Irinotecan 20 Capecitabine 20 toripalimab 18 Oxaliplatin 17 Leucovorin 17 Ipilimumab 17 Cetuximab 16 durvalumab 15 olaparib 13 Rifampin 12 Itraconazole 12 Midazolam 11 Cyclophosphamide 11 trifluridine tipiracil drug combination 10 spartalizumab 10 sintilimab 9 linifanib 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03951116 2022-03-16

FCN-437c

Fochon Pharmaceuticals, Ltd.

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡